4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000133
Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)
- Chief Legal Officer acquired 3,290 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,290 | $9.57 | $31,485 | 27,882 | D |
| 2024-10-14 | Sale : show line 2 in the form 10b5-1 | −3,290 | $25.00 | $82,250 | 24,592 | D |
| Open-market sales · 3,290 sh · avg $25.00 · $82,250 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-14 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −3,290 | 99,679 | D |
Loading xslF345X05/wk-form4_1728998177.xml…